A bioavailability and food effect study of AZD5462 in healthy volunteers

Trial Identifier: D9090C00005
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT05512806
Start Date: August 2022
Primary Completion Date: November 2022
Study Completion Date: November 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Spanish (US) Translation

Trial Locations

Country Location
US, MD Brooklyn, MD, US, 21225